Zimmer Biomet to acquire Monogram Technologies for $177 million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
BTIG Reiterates Buy Rating on Zimmer Biomet (ZBH)
July 14, 2025 12:17 PM EDTBTIG analyst Ryan Zimmerman reiterated a Buy rating and $117.00 price target on Zimmer Biomet (NYSE: ZBH).
The analyst comments "This morning, ZBH announced it has entered into a definitive agreement to acquire Monogram Technologies (MGRM, Not Rated) for $4.04 per share, equity value of ~$177M and enterprise value of ~$168M. The transaction also features a CVR worth up to $12.37 per share if all milestones are achieved... More
